Pierre J. Jordaan

Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (<scp>LCZ</scp>696) in Patients with Heart Failure and Reduced Ejection Fraction

Zhanna Kobalava, Yu. V. Kotovskaya, Diego Albrecht et al. · Cardiovascular Therapeutics · 2016 · 79 citations · Full text

Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials

Andy Mead, Hamid Amouzadeh, Kathryn Chapman et al. · Regulatory Toxicology and Pharmacology · 2016 · 65 citations · Full text

Neuropsychology, Neurophysiological Biomarkers, Predictive Value +21

Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor

Surya Ayalasomayajula, Thomas Langenickel, Pierre J. Jordaan et al. · European Journal of Clinical Pharmacology · 2016 · 41 citations

Hypertension, Renal Function, Medicine +5

Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes

Pierre J. Jordaan, Bérengère Dumotier, Martin Traebert et al. · Toxicological Sciences · 2021 · 27 citations · Full text

Heart Failure, Cardiovascular Pharmacology, Pharmacotherapy +17

Pre-slaughter mortality and post-slaughter wastage in bobby veal calves at a slaughter premises in New Zealand

G W Thomas, Pierre J. Jordaan · New Zealand Veterinary Journal · 2012 · 26 citations